SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-499266
Filing Date
2016-03-10
Accepted
2016-03-10 08:31:37
Documents
12
Period of Report
2016-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d156643d8k.htm 8-K 26413
2 EX-3.1 d156643dex31.htm EX-3.1 98220
3 EX-3.2 d156643dex32.htm EX-3.2 90503
4 EX-4.1 d156643dex41.htm EX-4.1 86873
5 EX-4.2 d156643dex42.htm EX-4.2 86555
6 EX-4.3 d156643dex43.htm EX-4.3 85324
7 EX-4.4 d156643dex44.htm EX-4.4 86727
8 EX-10.1 d156643dex101.htm EX-10.1 200951
9 EX-10.2 d156643dex102.htm EX-10.2 117301
10 EX-10.3 d156643dex103.htm EX-10.3 33498
11 EX-99.1 d156643dex991.htm EX-99.1 10611
12 GRAPHIC g156643ex10_3logo.jpg GRAPHIC 12390
  Complete submission text file 0001193125-16-499266.txt   941635
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 161496231
SIC: 2834 Pharmaceutical Preparations